Invus Financial Advisors, LLC - Q1 2023 holdings

$154 Million is the total value of Invus Financial Advisors, LLC's 8 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 11.1% .

 Value Shares↓ Weighting
CPNG SellCoupang Inccl a$35,945,136
-11.7%
2,246,571
-18.8%
23.41%
+8.1%
RCUS  Arcus Biosciences Inc$29,404,284
-11.8%
1,612,0770.0%19.15%
+8.0%
TBLA BuyTaboola.com Ltd$27,117,026
+12.6%
9,969,495
+27.5%
17.66%
+37.8%
 Nu Hldgs Ltd$26,574,842
+17.0%
5,582,9500.0%17.31%
+43.2%
NVCR  Novocure Ltd$21,102,164
-18.0%
350,8840.0%13.74%
+0.4%
 IONQ Inc$6,150,000
+78.3%
1,000,0000.0%4.01%
+118.2%
ORIC  Oric Pharmaceuticals Inc$5,743,178
-3.2%
1,007,5750.0%3.74%
+18.5%
 IHS Holding Limited$1,494,088
+42.4%
170,5580.0%0.97%
+74.4%
OYST ExitOyster Point Pharma Inc$0-2,768,586
-100.0%
-16.46%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Arcus Biosciences Inc16Q3 202324.7%
Novocure Ltd16Q3 202325.4%
Oric Pharmaceuticals Inc14Q3 202314.3%
Oyster Point Pharma Inc13Q4 202244.5%
Coupang Inc11Q3 202351.6%
Taboola.com Ltd10Q3 202323.7%
Unity Biotechnology Inc9Q4 20218.0%
Yext Inc8Q3 202130.3%
IONQ Inc8Q3 20237.2%
Nu Hldgs Ltd6Q3 202325.4%

View Invus Financial Advisors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Invus Financial Advisors, LLC's complete filings history.

Compare quarters

Export Invus Financial Advisors, LLC's holdings